In the 1970s, less than a quarter of people with cancer survived. But over the last 40 years, survival has doubled.
Our ambition is to accelerate progress and see three-quarters of people surviving the disease within the next 20 years.
We want survival in the USA to be among the best in the world. We’re focusing our efforts in four key areas – working to help prevent cancer, diagnose it earlier, develop new treatments and optimise current treatments by personalising them and making them even more effective.
We’ll continue to support research into all types of cancer and across all age groups. And we’re keeping our focus on understanding the biology of cancer so we can use this vital knowledge to save more lives.
We’re increasing our research in key areas such as early diagnosis, and hard-to-treat cancers including lung, pancreatic, oesophageal cancers and brain tumours.
We’re developing new tests, surgery and radiotherapy techniques, and cancer drugs. We want to personalise prevention, screening and treatment and bring benefits to patients sooner.
Being a doctor and researcher it is very important to help the cancer society. I am honored and previlaged that i could sponsor and actively take part in the 43rd ISOBM annual congress of Internatinal Society of Oncology and Biomarkers (ISOBM) which will take place in chicago from september 1st-6th, […]
It was my please to be part of the childrens day event held in Albany park libray chicago, IL. Thank you Honorary Counsul of Bangladesh, Mr. Monir Chowdhury for the invitation. The event was full of enthusiam and positive spirit for the everyone. I was honored to deliver the health awareness […]
Sponsorship helps children, families, and communities break the cycle of poverty. Humanitarian mission dedicated to working with children, families, and their communities worldwide to reach their full potential by tackling the causes of poverty and injustice. We serve alongside the poor and oppressed as a demonstration of love for all […]
Our dedication to cancer reserach support innovative approaches for early diagnosis and treatment of various cancers.
We are currently working on gene expression of various genes from the gene pool data analysis to figureout reasons for cancer development.
Time is shortening. But every day that our reasearch work challenges cancer and every single survivor is a victory for us.
Childhood hunger is a major problem in many countries, but it is solvable. Donate to feed hungry kids.
Dr.Juel Chowdhury MD
Juel Chowdhury began his professional education at the Gulf Medical University, UAE where he received his first profession degree in medicine (Doctor of Medicine). Since then, his works have led him to exchange scientific ideas with Nobel laureate Dr. Ferid Murad and many well-known scientists such as Dr. Robert Winn Director of UI health Chicago. He is the founder and president of Oncomarks.org an online professional network with an open access journal for the oncologists. His innovative iGenX lab is a gene research lab based on data-mining and data analysis of the various gene-chip experiments. Dr. Chowdhury is also proficient in several languages and computer programs. Reviewer of well-known journals like Tumor Biology and JCMT. Editorial Board member of JUMD, and many professional societies like ASCO and ISOBM. He was the director of ISOBM (International society of oncology and biomarkers) 2016 congress held in Chicago and also the member of Organizing Committee for the upcoming ISOBM 2017 congress which will be hosted in Brazil. He is an expert in Botulinum Toxin and Dermal Fillers, facial reconstruction and hair transplant procedures from Ohio,USA and Poland. He also contributed as an Organizing committee of 14th and upcoming 15th Transitional medicine and oncologist meet, San Francisco, CA.
Head & neck, lung & upper aero digestive tumors, tumor stem cells. Nitric oxide in tumor environment.
Read Full Resume